Europe in vitro diagnostics (IVD) market was valued at $ 21,682.6 million in 2021 and will grow by 6.5% annually over 2021-2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, burgeoning demand for automation in diagnostics, the rising development of condition-specific treatment and booming awareness regarding personalized medicines, emergence of minimally invasive and non-invasive diagnostics tools & techniques, the rising healthcare expenditure, and rise in the demand for POC testing.
Highlighted with 35 tables and 64 figures, this 138-page report "Europe In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire Europe in vitro diagnostics (IVD) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe in vitro diagnostics (IVD) market in every aspect of the classification from perspectives of Product, Technology, Sample Type, Application, End User, and Country.
Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments & Devices
o Disposable IVD Devices
o Reusable IVD Devices
• Reagents & Kits
• Software & Services
Based on Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Clinical Chemistry
• Molecular Diagnostics
• Immuno Diagnostics
• Hematology
• Tissue Diagnostics
• Microbiology
• Coagulation and Hemostasis
• Urinalysis
• Other Technologies
By Sample Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Blood
• Mucus
• Urine
• Other Sample Types
By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Infectious Diseases
• Diabetes
• Cancer/Oncology
• Cardiology
• Autoimmune Disease
• Nephrology
• Drug Testing
• HIV/AIDS
• Other Applications
By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Diagnostic Laboratories
• Hospitals and Clinics
• Homecare Settings
• Point-of-Care (POC) Settings
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Netherlands
• Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Application and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories, Inc.
Agilent Technologies, Inc.
Arkray Inc.
Becton, Dickinson and Company
Biomerieux SA
Bio-Rad Laboratories Inc.
Danaher Corporation
DiaSorin SpA (Luminex Corporation)
Epic Systems Corporation
F. Hoffmann-La Roche Ltd.
Genpact Limited
Grifols SA
IBM Corporation
Mckesson Corporation
Ortho Clinical Diagnostics Inc.
Qiagen NV
Quest Diagnostics Inc.
Quidel Corporation
Roche Diagnostics
Siemens Healthineers
Sysmex Corporation
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porter's Fiver Forces Analysis 39
3 Segmentation of Europe Market by Product 43
3.1 Market Overview by Product 43
3.2 Instruments & Devices 45
3.2.1 Disposable IVD Devices 46
3.2.2 Reusable IVD Devices 47
3.3 Reagents & Kits 48
3.4 Software & Services 49
4 Segmentation of Europe Market by Technology 50
4.1 Market Overview by Technology 50
4.2 Clinical Chemistry 52
4.3 Molecular Diagnostics 53
4.4 Immuno Diagnostics 54
4.5 Hematology 55
4.6 Tissue Diagnostics 56
4.7 Microbiology 57
4.8 Coagulation and Hemostasis 58
4.9 Urinalysis 59
4.10 Other Technologies 60
5 Segmentation of Europe Market by Sample Type 61
5.1 Market Overview by Sample Type 61
5.2 Blood 63
5.3 Mucus 64
5.4 Urine 65
5.5 Other Sample Types 66
6 Segmentation of Europe Market by Application 67
6.1 Market Overview by Application 67
6.2 Infectious Diseases 69
6.3 Diabetes 79
6.4 Cancer/Oncology 80
6.5 Cardiology 81
6.6 Autoimmune Disease 82
6.7 Nephrology 83
6.8 Drug Testing 84
6.9 HIV/AIDS 85
6.10 Other Applications 86
7 Segmentation of Europe Market by End User 87
7.1 Market Overview by End User 87
7.2 Diagnostic Laboratories 89
7.3 Hospitals and Clinics 90
7.4 Homecare Settings 91
7.5 Point-of-Care (POC) Settings 92
7.6 Other End Users 93
8 European Market 2021-2031 by Country 94
8.1 Overview of European Market 94
8.2 Germany 97
8.3 U.K. 99
8.4 France 101
8.5 Spain 103
8.6 Italy 105
8.7 Netherlands 107
8.8 Rest of European Market 109
9 Competitive Landscape 111
9.1 Overview of Key Vendors 111
9.2 New Product Launch, Partnership, Investment, and M&A 114
9.3 Company Profiles 115
Abbott Laboratories, Inc. 115
Agilent Technologies, Inc. 117
Arkray Inc. 118
Becton, Dickinson and Company 119
Biomerieux SA 120
Bio-Rad Laboratories Inc. 121
Danaher Corporation 122
DiaSorin SpA (Luminex Corporation) 123
Epic Systems Corporation 124
F. Hoffmann-La Roche Ltd. 125
Genpact Limited 126
Grifols SA 127
IBM Corporation 128
Mckesson Corporation 129
Ortho Clinical Diagnostics Inc. 130
Qiagen NV 131
Quest Diagnostics Inc. 132
Quidel Corporation 133
Roche Diagnostics 134
Siemens Healthineers 135
Sysmex Corporation 136
Thermo Fisher Scientific Inc. 137
RELATED REPORTS 138
Market Overview
The Europe Banking as a Service (BaaS) Market is set to experience significant growth from 2024 to 2034, driven by the rapid digital transformation of the financial sector, the increasing adoption of embedded finance solutions, and the rising demand for seamless customer...
Market Overview
The Europe Perfume Packaging Market is poised for substantial growth from 2024 to 2034, fueled by rising consumer demand for premium fragrances, evolving aesthetic preferences, and the growing emphasis on sustainable packaging solutions. The market is projected to achiev...
Market Overview
The Europe Alternate Marine Power (AMP) Market is set to witness remarkable growth from 2024 to 2034, driven by stringent environmental regulations, increasing adoption of green maritime technologies, and the pressing need to reduce greenhouse gas (GHG) emissions in the ...
Market Overview
The Europe Bio Vanillin Market is poised for significant growth from 2024 to 2034, driven by rising consumer preference for natural and sustainable food ingredients, stringent regulatory measures against synthetic additives, and increasing applications in diverse industr...
Market Overview
The Europe AI-Enabled Biometric Market is expected to experience substantial growth from 2024 to 2034, driven by the rising demand for enhanced security systems, increasing adoption of artificial intelligence (AI) technologies, and the need for more efficient biometric i...
Market Overview
The Europe Commercial Vehicle Telematics Market is set to experience robust growth from 2024 to 2034, driven by the increasing adoption of connected technologies, enhanced fleet management solutions, and the need for real-time data analytics across commercial vehicle ope...
Market Overview
The Europe Passive Optical Network (PON) Market is anticipated to experience significant growth from 2024 to 2034, driven by the increasing demand for high-speed internet, data services, and the transition towards fiber-based broadband solutions. As fiber-optic networks ...
Market Overview
The Europe Safety Valves Market is projected to witness steady growth from 2024 to 2034, driven by rising demand across critical industries such as oil and gas, energy and power, and water treatment. With increased focus on safety and regulatory compliance, the market is...
Market Overview
The Europe Vanadium Market is poised for significant growth from 2024 to 2034, driven by increasing demand across diverse industries such as iron and steel production, energy storage, and chemicals. The market is expected to reach USD XX.XX billion by 2034, expanding at ...
Market Overview
The Europe Vascular Closure Devices Market is poised for significant growth from 2024 to 2034, driven by advancements in minimally invasive procedures, increasing procedural volumes, and a growing preference for vascular closure solutions that enhance patient outcomes. T...